We develop new therapies in fibrosis and oncology by unlocking the biology of aminoacyl tRNA synthetases and related proteins.
We leverage research and development capabilities of Biocon in Korea and commercial expertise in the United States and Europe.
Copyright © 2019 Excubio Pharmaceuticals Inc. - All Rights Reserved.